project id: TCGA-HNSC; case submitter id: TCGA-CQ-A4CI; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.82; rna integrity number: 9.1; age at index: 73; days to birth: -26664; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1938; age at diagnosis: 26664; ajcc clinical m: MX; ajcc clinical n: NX; ajcc clinical t: TX; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 950.0; icd 10 code: C06.0; last known disease status: not reported; morphology: 8083/3; primary diagnosis: Basaloid squamous cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cheek mucosa; synchronous malignancy: No; tissue or organ of origin: Cheek mucosa; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Yes; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; years smoked: 40.0; is ffpe: false; weight: 20.0; composition: Not Reported; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-CQ-A4CI-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 10.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 40.0; percent tumor nuclei: 75.0;